Does the anthropometric profile influence infection morbidity after coronary artery bypass grafting?

Fernando A Atik1, Hélio M Pegado1, Larissa M R de Brito1

  • 1Department of Cardiovascular Surgery, Instituto de Cardiologia do Distrito Federal, Brasilia, Distrito Federal, Brazil.

Insights

While overall infection risk after coronary artery bypass grafting is not strongly linked to body mass index, obesity is a significant predictor of superficial and deep sternal wound infections. Careful patient selection and management of modifiable factors are crucial.

Area of Science:

  • Cardiovascular Surgery
  • Infectious Disease Epidemiology
  • Surgical Outcomes Research

Background:

  • Post-cardiovascular surgery infection is a complex issue with multiple contributing factors.
  • The influence of patient anthropometric profiles on infection rates following isolated coronary artery bypass grafting (CABG) requires investigation.

Purpose of the Study:

  • To investigate the association between body mass index (BMI) classifications and the incidence of infection after isolated coronary artery bypass grafting (CABG).
  • To identify independent predictors of infection following CABG, considering various patient and procedural characteristics.

Main Methods:

  • A cohort of 1777 adult patients undergoing isolated CABG between January 2011 and June 2016 was analyzed.
  • Patients were stratified into four BMI groups: underweight, normal, overweight, and obese.
  • Multiple Poisson regression with robust variance was employed to determine independent predictors of infection morbidity.

Main Results:

  • Independent predictors for any infection included female sex, age over 60, prolonged cardiopulmonary bypass time, recent myocardial infarction, diabetes mellitus, low ejection fraction, and blood transfusion.
  • Obesity and diabetes mellitus were identified as independent predictors specifically for superficial and deep sternal wound infections.

Conclusions:

  • Factors beyond anthropometric profile are more critical for overall infection risk post-CABG.
  • Obese patients exhibit a higher frequency of surgical site infections.
  • Optimizing patient selection, managing modifiable risk factors, and implementing surgical bundles can mitigate infection complications.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.0K
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
134
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
111
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
670
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
124
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
475